Cannara Biotech Inc

Cannara Biotech Inc. (TSXV: LOVE) is a vertically integrated producer of premiumgrade cannabis and cannabisderivative products for the Quebec and Canadian markets. The Companys main focus is to deliver craftquality AAAA products at disruptive retail pricing, continuous rotation of rare genetics, community responsiveness and transparency to collectively add to its value proposition. Leveraging the provinces low electricity and labor rates, Cannara owns two mega Quebec based facilities spanning over 1,650,000 sq. ft., providing up to 125,000kg of annualized cultivation output

Cannabis,thc/cbd derivative products,vertically integrated,publicly traded company,cannabis extracts,cannabis flower,canadian cannabis,cannabis licensed producer,cannabis company ,produits dérivés du thc/cbd,intégration verticale,société cotée en bourse,extraits de cannabis,fleurs de cannabis,cannabis canadien,pré-rouleaux de cannabis,société de cannabis,and producteur agréé de cannabis

Cannara biotech inc operates in the Biotechnology research industry.

Cannara biotech inc's revenue is $55.50m

Cannara biotech inc has 51 - 200 employees.